Serum Testosterone: A Potentially Adjunct Screening Test for the Assessment of the Risk of Prostate Cancer Among Men with Modestly Elevated PSA Values (≥3.0 and <10.0 ng/ml)

Whether serum testosterone (T) can become an adjunct test able to validate the PSA-weighted risk of prostate cancer (PR.CA) in the “grey” diagnostic area (PSA =3.0 to

Saved in:
Bibliographic Details
Published in:Anticancer research 2006-07, Vol.26 (4B), p.3159-3166
Main Authors: KARAMANOLAKIS, Dimitrios, LAMBOU, Theocharis, KOUTSILIERIS, Michael, BOGDANOS, John, MILATHIANAKIS, Constantine, SOURLA, Antigone, LEMBESSIS, Peter, HALAPAS, Antonis, PISSIMISSIS, Nicholas, DESSYPRIS, Nick, PETRIDOU, Eleni T. H
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Biological and medical sciences
Biopsy - methods
Humans
Male
Mass Screening - methods
Medical sciences
Middle Aged
Neoplasm Staging
Nephrology. Urinary tract diseases
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Risk Factors
Testosterone - blood
Tumors
Tumors of the urinary system
Ultrasonography
Urinary tract. Prostate gland
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Whether serum testosterone (T) can become an adjunct test able to validate the PSA-weighted risk of prostate cancer (PR.CA) in the “grey” diagnostic area (PSA =3.0 to
ISSN:0250-7005
1791-7530